Finland’s National Institute for Health and Welfare joins SNOMED International as the organization’s 36th Member.
London, United Kingdom, Dec. 19, 2018 (GLOBE NEWSWIRE) -- SNOMED International and the Finnish National Institute for Health and Welfare (THL) are pleased to announce that Finland has joined the organization as its thirty-sixth Member.
Finland, one of the leading nations in the area of information and communication technology, has set the development of eHealth technologies as a high priority and has quickly become a pioneer in digital health. Its largest national digital healthcare project, the Kanta Service, i.e. the National Archive of Health Information, is one of the most comprehensive systems of its kind globally, covering already the entire Finnish public healthcare sector as well as most of the private sector. The development of Kanta Service began around 2005, and the first laws concerning the digital service were enacted in 2007.
A prerequisite to this being the development of information systems and standards and particularly their usability. The Kanta Service is a collaborative undertaking among the Social Insurance Institution of Finland (Kela), the National Institute for Health and Welfare (THL), the Ministry of Social Affairs and Health, and various social and healthcare organizations.
As the newest SNOMED International Member, Finland will leverage SNOMED CT’s
structured clinical vocabulary to structure its Kanta Service and realize improvements in how clinical data is recorded, analyzed and reported on for the benefit of patient care. Finland’s commitment to SNOMED CT sets a foundation for clinical data to be exchanged accurately and consistently across Finnish health and social care settings, further extending the reach of structured clinical terminology throughout the European region.
To make best use of SNOMED CT with available resources, Finland has chosen not to translate the whole terminology. Instead, the aim is to focus on two national reference sets that meet local needs in areas where there is international experience and models showing implementation success. The first target is an obvious one: standardizing the terminology and codes for anatomic pathology in the clinical laboratories. Finnish pathology laboratories have used SNOMED 2 since 1980’s. But lack of coordination eventually resulted in several dialects and variance between hospitals. Now the ongoing project aims at national reference set to help the biobanks, regional and national quality registers and structured reporting on individual patient basis.
The other chosen application for SNOMED CT is patient problem list. Finland decided to use CORE Problem List as foundation for the local effort. CORE Problem List originated from a respectable group of medical institutions in the U.S. and is maintained by the National Medical Library thus making the acceptance of the reference set by clinicians so much easier. The ongoing project translates terminology into Finnish and when finished will cover terms for both professionals and patients. Our aim is to have these first two applications ready at the first half of 2020. SNOMED CT National Release Center will gradually take off during 2019 and 2020 to meet the needs for services and support during SNOMED CT local implementations. SNOMED CT NRC will be essential part of THL Code Service.
SNOMED CT is the world’s most comprehensive health terminology. Founded in 2007 by nine charter nations, SNOMED International is a not-for-profit, member-owned and driven international organization. CEO, Don Sweete, is excited to add Finland to SNOMED International’s European Member base. “Finland’s leading-edge digital expertise stems from years as leaders of the information technology and communications industry.” Since then, the strong Finnish ICT experience has permeated nearly every industrial sector including health. Digital health technology is certainly one of the most compelling and promising of these fields with the Kanta Service, and Finland’s commitment to adopting SNOMED CT’s clinical terminology to support care delivery, data analysis and research is encouraging.”
Finland is the twenty-third country in the Europe, Middle East and African region (EMEA) to join SNOMED International, strengthening the position of the area for increased interoperability amongst its regional and international counterparts as was echoed in the 2017 ASSESS CT report.
To learn more about SNOMED International and SNOMED CT, visit www.snomed.org.
To learn more about Finnish healthcare visit https://thl.fi/en/web/information-management-in-social-welfare-and-health-care. For more information on Kanta services visit http://www.kanta.fi/en and http://www.finlandhealth.fi/home.
About SNOMED International:
SNOMED International is a not-for-profit organization that owns and develops SNOMED CT, the world's most comprehensive healthcare terminology product. We play an essential role in improving the health of humankind by determining standards for a codified language that represents groups of clinical terms. This enables healthcare information to be exchanged globally for the benefit of patients and other stakeholders. We are committed to the rigorous evolution of our products and services, to deliver continuous innovation for the global healthcare community. SNOMED International is the trading name of the International Health Terminology Standards Development Organisation (IHTSDO.)
YouTube: SNOMED International
About National Institute for Health and Welfare (THL):
The National Institute for Health and Welfare (THL) is responsible for the operative guidance of the information management in social welfare and health care. As a statistical authority THL is responsible for the maintenance and development work of the statistical and register repositories and national classifications. The Operational Management Unit is responsible for the operational management of health and welfare information manages the national development of health and welfare information gives hospital districts, health centres, private health service providers, and pharmacies guidance in carrying out information-system reforms so that the introduction of services is managed within the time frames defined by law. We are an independent, expert agency working under the Ministry of Social Affairs and Health.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Bio-Fence announces a breakthrough in Food Safety18.1.2019 08:11 | Pressemelding
The company have successfully completed a field trial of its new anti-microbial coating technology. The trials demonstrated a significant reduction in bacterial contamination during sensitive food production processes ASHDOD, Israel, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Bio-Fence innovating coating technology announced today the successful completion of an intensive field trial on its innovative anti-microbial technology Pentagon. The trial was held in "Milouoff" (http://www.milouoff.co.il), one of the largest Ready to Eat poultry production sites in Israel and demonstrated superior results for Bio-Fence technology compared to alternatives. According to Mrs. Shiran Davidi, QA manager at Milouoff: “Bio-Fence technology seems to have clear benefits over existing antimicrobial solution. It is safe, highly potent and rechargeable.” The trial involved monitoring the performance of an epoxy floor coated with Bio-Fence anti-microbial technology compared to either commercial Silver Ion coating an
ERYTECH Presents TRYbeCA-1 Trial-in-Progress Poster at the 2019 ASCO GI Annual Meeting18.1.2019 07:00 | Pressemelding
LYON, France and CAMBRIDGE, Mass., Jan. 18, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, announced that a poster entitled “TRYbeCA-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)” will be presented today at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in San Francisco. The poster (Abstract # TPS471) will be available at www.erytech.com after presentation at the conference. In September 2018, the TRYbeCA-1 trial was initiated. The Trial-in-Progress poster will provide an update on the study progress with investigators sites that have been initiated in multiple countries and actively recruiting patients. The trial is planned to enroll approximately 500 patients with
Fossil Group Enters Agreement To Sell Select Smartwatch Technology To Google17.1.2019 18:30 | Pressemelding
Transaction Unlocks Growth Opportunities for Fossil Group’s Wearables Business RICHARDSON, Texas, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Today, Fossil Group (NASDAQ:FOSL) announced its plan to sell to Google for $40 million intellectual property (IP) related to a smartwatch technology currently under development by Fossil Group. As part of the transaction, a portion of Fossil Group’s research and development (R&D) team currently supporting the transferring IP will join Google. Fossil Group retains more than 200 R&D team members to focus on innovation and product development. The transaction showcases Fossil Group and Google’s shared investment in the wearables industry. In recent years, smartwatches have become Fossil Group’s fastest growing category. The company successfully developed and launched smartwatches across 14 of its owned and licensed brands. “Fossil Group has experienced significant success in its wearables business by focusing on product design and development informed by our
Calgon Carbon Corporation Announces Global Price Increase17.1.2019 17:16 | Pressemelding
Pittsburgh, PA, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Calgon Carbon Corporation today announced a global price increase, effective February 1, 2019, where contracts permit, on all activated carbon products and related equipment due to a continued escalation in raw material costs and transportation expenses. The increase is expected to range between 10-15%, depending on the specific product, raw material type, services provided, and global market dynamics. The primary raw materials used for producing activated carbon are coal, coconut shell, and wood, each of which has gone up in price. Additionally, costs associated with both operating manufacturing facilities and transporting materials have also escalated. “Calgon Carbon’s raw material costs have increased significantly. Despite every effort to offset these increases through continuous improvements, the recent rise in raw material costs has exceeded our efforts,” said Jim Coccagno, Chief Commercial Officer for Calgon Carbon Corporation. “
Taconic Biosciences’ Animals Complete Most Recent Mission to the International Space Station17.1.2019 15:29 | Pressemelding
RENSSELAER, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the completion of a recent mission to the International Space Station. This project represents a collaboration between the International Space Station (ISS) National Lab, National Aeronautics and Space Administration (NASA), Bioserve Space Technologies with support from the Leidos Corporation, and Taconic. Taconic has participated in several spaceflight missions with NASA since 1985. Most recently, as part of the science and research investigation payloads supported by the SpaceX Commercial Resupply Services missions, Taconic prepared mice to live aboard the International Space Station for extended periods. Previous spaceflight studies demonstrated that mice undergo rapid loss of muscle and bone mass, resembling accelerated aging. Therefore, mice exposed to microgravity via spaceflight are a valuable model to understand and devel
MPP Global Bridges the Innovation Gap by Centralising Physical and Digital Subscriber Management and Billing in a Single Cloud Platform17.1.2019 12:29 | Pressemelding
WARRINGTON, UK, Jan. 17, 2019 (GLOBE NEWSWIRE) -- MPP Global, the technology company that delivers eSuite, the world’s smartest subscriber management & billing platform, announces the launch of pivotal new functionality which enables media organisations to seamlessly create and manage the sale of physical subscriptions. This positions eSuite as the complete physical and digital subscription management solution. The development of this industry-first functionality was borne out of the common challenge for publishers when managing multiple systems for deploying bundled print and digital subscriptions. This is inflexible for publishers and limits choice for their customers, restricting the ability to seamlessly create and offer digital and print subscription bundles. Despite increased consumer uptake of digital subscriptions, print still accounts for almost 90% of circulation revenues globally. To drive reader revenues successfully, publishers require functionality to execute complementar